Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biotage Announces the Launch of ISOLUTE® PLD+

Published: Monday, January 27, 2014
Last Updated: Sunday, January 26, 2014
Bookmark and Share
Improved sensitivity with the new protein and phospholipid removal plate.

Biotage has announced the launch of ISOLUTE® PLD+, a protein and phospholipid removal plate for the clean-up of blood based matrix samples for analysis by LC-MS/MS.

ISOLUTE® PLD+ plates combine protein and phospholipid removal in a single product providing very effective and extremely simple sample clean-up for LC-MS/MS analysis. Utilizing our solvent crash / filter process the plates also incorporate a phospholipid scavenging sorbent layer, which removes phospholipids from the sample during the filtration step.

ISOLUTE® PLD+ plates remove more than 99% of plasma proteins and phospholipids, the main causes of ion suppression, leading to cleaner extracts and increased sensitivity, signal-to-noise, for a broad range of analytes.

Once purified, samples can be analyzed directly, or evaporated and reconstituted in a solvent that matches users analytical method requirements.

ISOLUTE® PLD+ plates can be processed using 96-well compatible positive pressure manifolds (such as the Biotage® Pressure+ 96), vacuum manifolds (for example the Biotage® VacMaster™ 96) and most automated liquid handling systems.

ISOLUTE® PLD+ is available in the standard SBS/ANSI standard 96-well plate format and typical sample volumes of 100 to 200 µL can be processed.

“Requiring next to no method development, ISOLUTE® PLD+ can be integrated quickly and easily into routine workflow, increasing productivity and reducing instrument downtime” said Paul Roberts, Analytical Product Manager, Biotage AB, Sweden.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biotage Receives its Largest Order to Date
Instruments, which originate from the recently acquired company Argonaut, will be used by chemists to enhance the processes used in the development of pharmaceuticals.
Friday, August 12, 2005
Biotage expands European presence

Wednesday, April 09, 2003
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.
Testing for Malaria or Cancer at Home
Chemist develops tech to save lives in rural Africa.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!